Ads
related to: Vertex Pharmaceuticals- Our Company
Learn about our mission and
the values that drive us.
- News
Stay current on all things Vertex
and discover the latest news.
- Contact Us
Find all the ways to reach us
for the information you need.
- Our Unique Approach
See What Makes Us Unique
And How We Put Science First.
- Our Company
Search results
Vertex acquires Alpine for $4.9 billion to expand portfolio
Investing.com· 6 days agoBOSTON & SEATTLE - Vertex Pharmaceuticals (NASDAQ: VRTX ) Incorporated (NASDAQ: VRTX) and Alpine...
Vertex buying Seattle biotech for $4.9 billion, its biggest acquisition ever - The Boston Globe
The Boston Globe· 5 days agoVertex Pharmaceuticals announced Wednesday that it would acquire a Seattle biotechnology company...
Vertex agrees to pay $4.9 billion for kidney disease drugmaker
Axios· 4 days agoVertex Pharmaceuticals has agreed to buy Alpine Immune Sciences, a Seattle-based biotech focused on...
Allspring Global Investments Holdings LLC Cuts Stake in Vertex Pharmaceuticals Incorporated...
ETF DAILY NEWS· 6 days agoAllspring Global Investments Holdings LLC cut its holdings in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Free Report) by 11.5% in the fourth quarter ...
Vertex pays $4.9 billion to hike Alpine’s immunology trail
FierceBiotech· 5 days agoVertex Pharmaceuticals is buying Alpine Immune Sciences for $4.9 billion, the companies announced...
Vertex's Alpine Acquisition: Unpacking Analyst Predictions on Povetacicept's Potential Impact - ...
Benzinga· 4 days agoOn Wednesday, Vertex Pharmaceuticals Incorporated VRTX agreed to acquire Alpine Immune Sciences Inc...
Biotech giant Vertex bought Alpine in a cash deal of $4.9 billion
Quartz· 5 days agoBiotech company Vertex Pharmaceuticals said it is acquiring Alpine Immune Sciences in a cash deal...
Could This Stock Be the Next Biotech Buyout?
Motley Fool via Yahoo Finance· 3 days agoThe biotechnology industry is getting more attention than usual following a buyout offer for Alpine Immune Sciences (NASDAQ: ALPN) from Vertex ...
Vertex to Pay $4.9 Billion for Kidney Disease Drug Developer
Bloomberg via Yahoo Finance· 5 days ago(Bloomberg) -- Vertex Pharmaceuticals Inc. agreed to buy Alpine Immune Sciences Inc. for a total...
Vertex Pharmaceuticals Moves Beyond $10B Cystic Fibrosis Franchise, Pays Around $5B For Kidney...
Benzinga· 5 days agoOn Wednesday, Vertex Pharmaceuticals Incorporated VRTX agreed to acquire Alpine Immune Sciences Inc ALPN for $65 per share or approximately $4.9 billion ...
Ad
related to: Vertex Pharmaceuticals
